Structure-guided discovery of 1,3,5-triazine–pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate-Reference-Cited by-同舟云学术

Structure-guided discovery of 1,3,5-triazine–pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate

Published:2014-08 Issue:15 Volume:24 Page:3321-3325
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Singh Babita,Bhat Hans Raj,Kumawat Mukesh Kumar,Singh Udaya Pratap

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Trends in Antimicrobial Drug Development: Implications for the Future

2. ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react, 2009, EMEA/576176/2009.

3. Where are all the new antibiotics? The new antibiotic paradox

4. Infectious Diseases Society of America. Bad Drugs, No Drugs; Infectious Diseases Society of America: Alexandria, Virginia, 2004.

5. Infectious Diseases Society of America, Clin. Infect. Dis. 2010, 50, 1081

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROCK Kinase Inhibitory Activity of Some Isoflavonoids and Their Pharmacological Significance in Glaucoma;Revista Brasileira de Farmacognosia;2024-04-04

2. Discovery of novel hybrids of Morpholino-1,3,5-triazine-pyrimidine as an anti-diabetic agent in High-fat, Low-dose Streptozotocin-induced diabetes in Wistar rats: An in-vitro, in-silico and in-vivo study;Journal of Molecular Structure;2023-12

3. Aminoquinoline-triazine Conjugates: Design, Synthesis, Antibacterial Activity, and SAR Analysis;Letters in Drug Design & Discovery;2023-03

4. Synthesis of novel s-triazine derivatives with substituted amines and its biological evaluation;Materials Today: Proceedings;2023

5. Discovery of novel 1,3,5‐triazines as potent antibacterial agent against urinary tract infection‐causing clinical isolates of Escherichia coli via inhibition of DNA Gyrase;Chemical Biology & Drug Design;2022-12-02